Evidence Development


The future of personalized medicine depends in part on the development of evidence to demonstrate the field's clinical and economic value.

In July of 2017, PMC supported a draft bill from Rep. Eric Swalwell (D-CA) that would provide for a study at the National Academy of Medicine (NAM) on the use of genetic and genomic testing to improve health care outcomes.


"Access to Precision Medicine Advancement Act"